Navigation Links
Equashield's Sales Grow by 60% in 2013
Date:1/14/2014

PORT WASHINGTON, New York, January 14, 2014 /PRNewswire/ --

Equashield (http://www.equashield.com), the leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, today announced that it has achieved 60% year-over-year sales growth for the fourth straight year.  

Equashield's closed systems reduce the risk of exposure for pharmacy technicians, pharmacists, nurses and other medical professionals who prepare and administer hazardous drugs, such as chemotherapy. In addition, the solution helps to prevent microbial ingress, decreasing the risk of infection in patients receiving these drugs.

"Approximately 20% of hospitals and medical centers are already investing in closed systems to ensure their employees' safety," said Marino Kriheli, Product Manager at Equashield. "With growing awareness of the many risks associated with hazardous drug exposure, this market is rapidly growing. In fact, 55% of new customers Equashield acquired this year did not use closed systems previously. Furthermore, with the recent launch of Equashield II, the company's second generation CSTD, we expect major sales growth to continue in 2014 and beyond."

Equashield is the only preassembled closed syringe that requires no further setup, making it quicker and easier to use than other system on the market. Equashield devices are currently used in the Cleveland Clinic, Mt. Sinai Hospital in New York and hundreds of other medical facilities.

Equashield II covers more routes of exposure to hazardous drugs than alternative systems and is the only system that prevents contamination of syringe plungers by hazardous drugs.

"Contamination on syringe plungers has been clearly identified in recent studies, added Kriheli. "The quantities of drug residue found on plungers place this route of exposure among the top risks associated with handling hazardous drugs."

About Equashield

Equashield is a leading developer of closed system drug transfer devices that protect healthcare professionals from hazardous drug and vapor exposure. EQUASHIELD® provides superior safety & ease-of-use by covering more routes of exposure than alternative systems and by enabling faster use than other systems. EQUASHIELD® is clinically proven to eliminate surface contamination with antineoplastic agents and prevent microbial ingress, having demonstrated the ability to extend beyond-use dating for single-use or non-preserved drugs. The system consists of a unique syringe with encapsulated barrel and plunger, built-in closed pressure equalization, and an integrated single motion connector that remains free of drug residue even after multiple connections. EQUASHIELD® is the only preassembled CSTD syringe on the market that requires no further setup, thereby contributing to ease of use and overall hospital productivity. For more information, visit http://www.equashield.com.

Media Contact:
Finn Partners for Equashield
Ellie Hanson
ellie@finnpartners.co.il
+972-54-467-6980


'/>"/>
SOURCE Equashield
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardica Appoints Industry Veteran Liam Burns As Vice President, Sales And Marketing
2. AMRI Hires George Svokos as Senior Vice President Sales and General Manager - API
3. FPR Specialty Pharmacy Hires Slomski To Lead Sales And Marketing; Moves To Next Phase In Cleveland Clinic Trials
4. Simbionix Welcomes New Latin and Central American Sales Manager
5. Immunotherapies Will Continue to Dominate the Malignant Melanoma Drug Market with Sales of Immune Checkpoint Inhibitors Accounting for Majority of Sales in this Drug Class in 2022
6. TRU-D SmartUVC Sales Soar in 2013 with Increased Acceptance of Proven Infection Prevention Technology
7. Indegene Named a Leader in IDC MarketScape: Worldwide Life Science Sales and Marketing BPO 2013 Vendor Assessment
8. Vermillion Appoints Marian E. Sacco as SVP of Sales and Marketing and Chief Commercial Officer
9. The Chronic Pain Drug Market Will Attain $21.6 Billion in Major-Market Sales by 2022
10. Osseon Announces New Regional Sales Director
11. Cantel Medical Reports 19% Sales Growth And EPS Of $0.27 vs. $0.23 For The First Quarter Ended October 31, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 2017 Under the impetus of the ... size increased year by year at the CAGR ... the market size will maintain the growth rate ... RMB140 billion in 2021, thanks to severe aging, ... biological agents and supporting policies. At present, ...
(Date:3/22/2017)...  CANTEL MEDICAL CORP. (NYSE: CMD ) announced ... will be presenting at the 16 th Annual Needham ... in New York . The formal presentation ... ET. In addition, management will be available for separate one-on-one ... webcast will be available via the investor relations page of ...
(Date:3/22/2017)... 22, 2017 Research and Markets has announced ... Trends - Industry Forecast to 2025" report to their offering. ... The Global ... around 7.1% over the next decade to reach approximately $129.81 billion ... and forecasts for all the given segments on global as well ...
Breaking Medicine Technology:
(Date:3/22/2017)... CT (PRWEB) , ... March 22, 2017 , ... ... historic plan to cure Rett Syndrome, a devastating neurological disorder that afflicts 350,000 ... MECP2, located on the X chromosome, and almost exclusively strikes females. Following ...
(Date:3/22/2017)... ... 22, 2017 , ... University Orthopedics (UOI) today announced the ... Hand, Upper Extremity and Microvascular Surgery at Newport Hospital. Dr. Bragdon specializes in ... and Hand Surgery. , As the leader of comprehensive orthopedic care in ...
(Date:3/22/2017)... Antonio, TX (PRWEB) , ... March 22, 2017 ... ... certified medical imaging core lab with extensive therapeutic experience and operational excellence in ... phase II immuno-oncology clinical trial for the treatment of non-small cell lung cancer ...
(Date:3/22/2017)... ... 22, 2017 , ... The Vanderbeck Agency, a Long Island firm providing insurance, ... embarking on a combined charity effort with the Great Neck Breast Cancer Coalition to ... the Great Neck Breast Cancer Coalition has worked to support breast cancer patients in ...
(Date:3/22/2017)... , ... March 22, 2017 , ... Schneider Insurance and ... and business owners throughout the Yellowstone Valley region, is launching a charity event aimed ... and botanical garden in all of Montana State, and is home to a broad ...
Breaking Medicine News(10 mins):